(H4Z3) HSBC MSCI Emerging Markets - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: IE000KCS7J59

Equity, Stocks, Emerging, China, India

Description: H4Z3 HSBC MSCI Emerging Markets

The HSBC MSCI Emerging Markets UCITS ETF USD Acc EUR is an exchange-traded fund listed on XETRA, tracking the Morningstar EM TME NR USD index. It provides investors with exposure to a diversified portfolio of emerging markets equities.

With Assets Under Management (AUM) of approximately €2.637 billion, this ETF is a sizable player in the Global Emerging Markets Equity category. The funds size indicates a reasonable level of liquidity, making it more accessible to investors.

To evaluate the ETFs performance, we can look at key metrics such as tracking error, expense ratio, and dividend yield. Although not directly provided, we can infer that the funds tracking error is likely to be low given its adherence to a well-established index. The expense ratio, a critical KPI, is not specified, but its typically a crucial factor in determining the funds overall cost-effectiveness. A lower expense ratio is generally more desirable as it directly impacts investors net returns.

From a technical analysis perspective, the ETFs price is currently at €11.40, slightly below its 20-day Simple Moving Average (SMA) of €11.45, indicating a potential short-term downward trend. However, its longer-term SMAs (50-day at €11.23 and 200-day at €11.03) suggest an overall upward trend, as the current price is above both. The Average True Range (ATR) of 0.07 (€0.62% of the current price) indicates relatively low volatility, which might be attractive to risk-averse investors.

Considering the ETFs 52-week high and low (€11.67 and €9.45, respectively), the current price is near its 52-week high, suggesting a strong recent performance. Investors should consider this in the context of their overall investment strategy and risk tolerance.

H4Z3 ETF Overview

Market Cap in USD 3,093m
Category Global Emerging Markets Equity
TER 0.15%
IPO / Inception 2022-06-28

H4Z3 ETF Ratings

Growth Rating 59.7%
Fundamental -
Dividend Rating -
Return 12m vs S&P 500 0.07%
Analyst Rating -

H4Z3 Dividends

Currently no dividends paid

H4Z3 Growth Ratios

Growth Correlation 3m 93.9%
Growth Correlation 12m 46.5%
Growth Correlation 5y 81%
CAGR 5y 9.53%
CAGR/Max DD 3y 0.51
CAGR/Mean DD 3y 2.32
Sharpe Ratio 12m 0.61
Alpha -0.21
Beta 0.814
Volatility 12.65%
Current Volume 97.6k
Average Volume 20d 47.9k
Stop Loss 11.8 (-3%)
Signal -0.81

What is the price of H4Z3 shares?

As of September 15, 2025, the stock is trading at EUR 12.17 with a total of 97,552 shares traded.
Over the past week, the price has changed by +2.97%, over one month by +4.03%, over three months by +9.14% and over the past year by +18.34%.

Is HSBC MSCI Emerging Markets a good stock to buy?

Partly, yes. Based on ValueRay´s Analyses, HSBC MSCI Emerging Markets (XETRA:H4Z3) is currently (September 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 59.65 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of H4Z3 is around 11.48 EUR . This means that H4Z3 is currently overvalued and has a potential downside of -5.67%.

Is H4Z3 a buy, sell or hold?

HSBC MSCI Emerging Markets has no consensus analysts rating.

What are the forecasts/targets for the H4Z3 price?

Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 12.9 5.7%

H4Z3 Fundamental Data Overview

Market Cap USD = 3.09b (2.64b EUR * 1.1726 EUR.USD)
Market Cap EUR = 2.64b (2.64b EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = unknown
Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 EUR
Beta = 0.0
Revenue TTM = 0.0 EUR
EBIT TTM = 0.0 EUR
EBITDA TTM = 0.0 EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 2.64b EUR (2.64b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 2.64b)
FCF Margin = unknown (Revenue TTM is 0)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 2.64b / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = unknown
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = none (Debt none / FCF TTM 0.0)
Total Stockholder Equity = unknown
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
RoIC = unknown (NOPAT none, Invested Capital 0.0, Ebit 0.0)
WACC = unknown (E(2.64b)/V(0.0) * Re(9.01%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(none)))
Discount Rate = 9.01% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)

Additional Sources for H4Z3 ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle